The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for Alphatec Holdings Inc is $15.00, about 47.8% above its August 3 closing price of $10.15
The stock recently traded at 21 times the next 12-month earnings vs. a P/E of 27 three months ago
